Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Sell
2,576
-584
-18% -$49.9K ﹤0.01% 2008
2026
Q1
$283K Sell
3,160
-135
-4% -$13K ﹤0.01% 1793
2025
Q4
$306K Buy
3,295
+399
+14% +$43.5K ﹤0.01% 1729
2025
Q3
$361K Buy
2,896
+57
+2% +$7.25K ﹤0.01% 1614
2025
Q2
$374K Buy
2,839
+240
+9% +$27.2K ﹤0.01% 1588
2025
Q1
$272K Sell
2,599
-6,712
-72% -$703K ﹤0.01% 1673
2024
Q4
$1.01M Buy
9,311
+651
+8% +$72.7K 0.01% 978
2024
Q3
$925K Buy
8,660
+1,450
+20% +$147K 0.01% 1007
2024
Q2
$713K Buy
+7,210
New +$726K 0.01% 1116

Other funds holding ITRI

Atria Investments's ITRI Position: Q2 2026 in Review

Atria Investments reduced its Itron (ITRI) stake by 18% in Q2 2026, selling an estimated $49.9K and leaving 2,576 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

Atria Investments first reported a position in ITRI in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.01M in Q4 2024. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Atria Investments held 2,576 shares of Itron worth $223K as of Q2 2026.
  • Atria Investments sold 584 Itron shares in Q2 2026, an estimated $49.9K.
  • Itron made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2008 holding.
  • Atria Investments first reported a position in Itron in Q2 2024 and has held it in 9 quarters since.
  • Atria Investments's Itron position peaked at $1.01M in Q4 2024.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.